With over 35 years of experience, SeerPharma has been at the forefront of supporting cutting-edge medical device and medtech companies in Quality and GxP compliance. Over the years, we have witnessed the rapid rise of implantables, neurotech, and diagnostic technologies—areas that continue to shape the future of healthcare.
In line with this evolution, we are proud to sponsor and chair BioMelbourne Network’s inaugural BioSymposium in 2025. This landmark event will bring together thought leaders from research, industry, and clinical practice to showcase advancements in implantables, neurostimulation, bioelectronics, and diagnostics.
Event Details
Date: Tuesday, 25th March 2025
Time: 8:45 AM – 5:00 PM AEDT
Location: Cliftons, Level 2, 440 Collins Street, Melbourne
SeerPharma’s Medical Device Consultant, Hayley Cameron, will chair the session: Manufacturing Innovation – Building Medtech for the Future
This session will explore:
- Advancing manufacturing capabilities for implantable devices and neurotech
- Precision engineering, material science, and the journey from lab innovation to market-ready technology
- Navigating regulatory challenges and scaling medtech manufacturing
Industry Leaders Joining This Session:
- Dr. Lewis Blackman – Director, Biomedical Materials Translational Facility, CSIRO
- Professor Arthur Lowery – Chief Investigator, ARC Centre of Excellence; Director, Monash Vision Group, Monash University
- Gil Rind – Director of R&D, Neo-Bionica
Whether you're a researcher, clinician, entrepreneur, or investor, this event will offer a rare opportunity to engage with industry pioneers, connect with key stakeholders, and contribute to shaping the future of MedTech.
For more information and to register, please click here to visit the event webpage.
Providing our insights, and supporting our industry in this way, is just another way we “Advance Quality and GMP Best-Practices in the APAC region”.
